who should not take glp-1 receptor agonists Medications: Everything You Need to Know The GLP-1 Agonists and Obesity:

GLP-1 RAs reduced the composite outcome of all-cause mortality and HF hospitalization by 27% (HR 0.73

Electrolyte Solutions: (Generic Pedialyte) Essential for combating the systemic dehydration commonly caused by GLP-1 medications

Both methods were time-consuming, expensive and imprecise (Randle

Tresiba has been shown to be cardiovascular-safe (non-inferior to placebo) in the DEVOTE trial, but it has not demonstrated the cardiovascular benefit that GLP-1 medications provide

This made him hesitant about the clinical value of creating antagonists to histamine, compounds able to block the hormone's action

doi: 10.1056/NEJMoa1305889